consuming them frequently will effectively cancel out the benefits of the supplement
Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L
You feel fuller sooner during meals, you stay satisfied longer between meals, and youre less likely to experience sudden hunger pangs or cravings
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Yet unanswered questions regarding this program remain, and the FAQs note that further information will be released in spring 2026